1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )
                )
            [credentials] => Array
                (
                    [method] => guest
                )
        )
)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )
                )
            [credentials] => Array
                (
                    [method] => guest
                )
        )
)
Table 2: Multivariate analysis of factors influencing symptomatic ICH and functional independence
Factors Mean 95% CI P Value Influencing symptomatic ICH  Intraprocedural heparin ≥3000 IU 3547 ± 588 IU 2377–4718 .01  ASPECTS ≤7 6.6 ± 0.4 5.8–7.4 .001  MT attempts ≥3 3.3 ± 0.3 2.6–4.1 .002 Influencing functional independence (mRS ≤2)  ASPECTS ≥8 8.4 ± 0.4 7.9–9.2 .001  MT attempts ≤2 1.9 ± 0.3 1.3–2.5 .004